Cargando…
Proteasome Complexes and Their Heterogeneity in Colorectal, Breast and Pancreatic Cancers
Targeting the ubiquitin-proteasome system (UPS) - in particular, the proteasome complex - has emerged as an attractive novel cancer therapy. While several proteasome inhibitors have been successfully approved by the Food and Drug Administration for the treatment of hematological malignancies, the cl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040722/ https://www.ncbi.nlm.nih.gov/pubmed/33854609 http://dx.doi.org/10.7150/jca.52414 |